HIMS This is it, folks. It’s a make-or-break moment for Hims. It’s right on the trendline. Compound drugs are on borrowed time. I never understood the bull thesis on this company.
Growth means little when the drug policy that allows for that growth is at risk. 👀
As always, I share my opinions and trades. I’m not suggesting anyone follow my trades. You do you.